Compare Encompass Health Corp. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROCE of 18.36%
2
Poor long term growth as Net Sales has grown by an annual rate of 4.26% and Operating profit at 9.42% over the last 5 years
3
The company has declared Positive results for the last 7 consecutive quarters
4
With ROCE of 21.99%, it has a very expensive valuation with a 3.82 Enterprise value to Capital Employed
Stock DNA
Pharmaceuticals & Biotechnology
USD 11,547 Million (Small Cap)
15.00
NA
0.63%
0.99
31.13%
4.74
Revenue and Profits:
Net Sales:
1,587 Million
(Quarterly Results - Mar 2026)
Net Profit:
232 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.67%
0%
1.67%
6 Months
-7.04%
0%
-7.04%
1 Year
-8.79%
0%
-8.79%
2 Years
24.77%
0%
24.77%
3 Years
71.55%
0%
71.55%
4 Years
104.78%
0%
104.78%
5 Years
57.88%
0%
57.88%
Encompass Health Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.03%
EBIT Growth (5y)
10.21%
EBIT to Interest (avg)
4.92
Debt to EBITDA (avg)
2.35
Net Debt to Equity (avg)
0.95
Sales to Capital Employed (avg)
1.22
Tax Ratio
18.96%
Dividend Payout Ratio
13.00%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
18.36%
ROE (avg)
27.24%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
4.74
EV to EBIT
13.26
EV to EBITDA
10.11
EV to Capital Employed
2.88
EV to Sales
2.35
PEG Ratio
0.56
Dividend Yield
0.63%
ROCE (Latest)
21.70%
ROE (Latest)
31.13%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 129 Schemes (46.6%)
Foreign Institutions
Held by 228 Foreign Institutions (16.47%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,586.60
1,544.60
2.72%
Operating Profit (PBDIT) excl Other Income
388.90
369.80
5.16%
Interest
31.80
30.20
5.30%
Exceptional Items
-0.40
0.00
Consolidate Net Profit
231.80
201.90
14.81%
Operating Profit Margin (Excl OI)
190.10%
183.50%
0.66%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.72% vs 4.54% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 14.81% vs 15.57% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
5,935.20
5,373.20
10.46%
Operating Profit (PBDIT) excl Other Income
1,381.00
1,164.10
18.63%
Interest
123.20
137.40
-10.33%
Exceptional Items
0.00
-0.60
100.00%
Consolidate Net Profit
758.60
596.60
27.15%
Operating Profit Margin (Excl OI)
177.40%
160.90%
1.65%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 10.46% vs 11.91% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 27.15% vs 26.24% in Dec 2024
About Encompass Health Corp. 
Encompass Health Corp.
Pharmaceuticals & Biotechnology
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. It is an owner and operator of inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on both an inpatient and outpatient basis. It offers its home health and hospice services through Encompass Home Health and Hospice business (Encompass). Encompass operates home health and hospice agencies in 30 states, with concentrations in the Southeast, Oklahoma, and Texas. As of December 31, 2018, the Company operated 130 inpatient rehabilitation hospitals.
Company Coordinates 
Company Details
9001 Liberty Pkwy , BIRMINGHAM AL : 35242-7509
Registrar Details






